{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T15:36:14Z","timestamp":1681486574085},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00380-017-1066-4","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T23:21:08Z","timestamp":1508800868000},"page":"413-420","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of tolvaptan on urine output in hospitalized heart failure patients with hypoalbuminemia or proteinuria"],"prefix":"10.1007","volume":"33","author":[{"given":"Koji","family":"Takagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Sone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Tokuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Omote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arifumi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Amitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Imura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"1066_CR1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cardfail.2014.01.016","volume":"20","author":"JL Bonilla-Palomas","year":"2014","unstructured":"Bonilla-Palomas JL, Gamez-Lopez AL, Moreno-Conde M, Lopez-Ibanez MC, Anguita-Sanchez M, Gallego de la Sacristana A, Garcia-Catalan F, Villar-Raez A (2014) Hypoalbuminemia in acute heart failure patients: causes and its impact on hospital and long-term mortality. J Card Fail 20:350\u2013358","journal-title":"J Card Fail"},{"key":"1066_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/eurjhf\/hfr154","volume":"14","author":"M Liu","year":"2012","unstructured":"Liu M, Chan CP, Yan BP, Zhang Q, Lam YY, Li RJ, Sanderson JE, Coats AJ, Sun JP, Yip GW, Yu CM (2012) Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 14:39\u201344","journal-title":"Eur J Heart Fail"},{"key":"1066_CR3","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ahj.2010.09.004","volume":"160","author":"S Uthamalingam","year":"2010","unstructured":"Uthamalingam S, Kandala J, Daley M, Patvardhan E, Capodilupo R, Moore SA, Januzzi JL Jr (2010) Serum albumin and mortality in acutely decompensated heart failure. Am Heart J 160:1149\u20131155","journal-title":"Am Heart J"},{"key":"1066_CR4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ki.1987.192","volume":"32","author":"M Inoue","year":"1987","unstructured":"Inoue M, Okajima K, Itoh K, Ando Y, Watanabe N, Yasaka T, Nagase S, Morino Y (1987) Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 32:198\u2013203","journal-title":"Kidney Int"},{"key":"1066_CR5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/1074248412474347","volume":"18","author":"BE Bleske","year":"2013","unstructured":"Bleske BE, Clark MM, Wu AH, Dorsch MP (2013) The effect of continuous infusion loop diuretics in patients with acute decompensated heart failure with hypoalbuminemia. J Cardiovasc Pharmacol Ther 18:334\u2013337","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"1066_CR6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.ajkd.2016.08.027","volume":"69","author":"EJ Hoorn","year":"2017","unstructured":"Hoorn EJ, Ellison DH (2017) Diuretic resistance. Am J Kidney Dis 69:136\u2013142","journal-title":"Am J Kidney Dis"},{"key":"1066_CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCHEARTFAILURE.109.881805","volume":"3","author":"S Masson","year":"2010","unstructured":"Masson S, Latini R, Milani V, Moretti L, Rossi MG, Carbonieri E, Frisinghelli A, Minneci C, Valisi M, Maggioni AP, Marchioli R, Tognoni G, Tavazzi L, GISSI-HF Investigators (2010) Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial. Circ Heart Fail 3:65\u201372","journal-title":"Circ Heart Fail"},{"key":"1066_CR8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijcard.2016.04.100","volume":"215","author":"MA Brisco","year":"2016","unstructured":"Brisco MA, Zile MR, Ter Maaten JM, Hanberg JS, Wilson FP, Parikh C, Testani JM (2016) The risk of death associated with proteinuria in heart failure is restricted to patients with an elevated blood urea nitrogen to creatinine ratio. Int J Cardiol 215:521\u2013526","journal-title":"Int J Cardiol"},{"key":"1066_CR9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","volume":"12","author":"JM Maaten ter","year":"2015","unstructured":"ter Maaten JM, Valente MA, Damman K, Hillege HL, Navis G, Voors AA (2015) Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat Rev Cardiol 12:184\u2013192","journal-title":"Nat Rev Cardiol"},{"key":"1066_CR10","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","volume":"297","author":"M Gheorghiade","year":"2007","unstructured":"Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C (2007) Efficacy of vasopressin antagonism in Heart Failure Outcome Study With Tolvaptan I. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 297:1332\u20131343","journal-title":"JAMA"},{"key":"1066_CR11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1253\/circj.CJ-66-0093","volume":"78","author":"K Kinugawa","year":"2014","unstructured":"Kinugawa K, Sato N, Inomata T, Shimakawa T, Iwatake N, Mizuguchi K (2014) Efficacy and safety of tolvaptan in heart failure patients with volume overload. Circ J 78:844\u2013852","journal-title":"Circ J"},{"key":"1066_CR12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0735-1097(03)00758-7","volume":"42","author":"S Arques","year":"2003","unstructured":"Arques S, Ambrosi P, Gelisse R, Luccioni R, Habib G (2003) Hypoalbuminemia in elderly patients with acute diastolic heart failure. J Am Coll Cardiol 42:712\u2013716","journal-title":"J Am Coll Cardiol"},{"key":"1066_CR13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCHEARTFAILURE.113.000828","volume":"7","author":"SR Goldsmith","year":"2014","unstructured":"Goldsmith SR, Bart BA, Burnett J (2014) Decongestive therapy and renal function in acute heart failure: time for a new approach? Circ Heart Fail 7:531\u2013535","journal-title":"Circ Heart Fail"},{"key":"1066_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/hepr.12098","volume":"44","author":"I Sakaida","year":"2014","unstructured":"Sakaida I, Kawazoe S, Kajimura K, Saito T, Okuse C, Takaguchi K, Okada M, Okita K, Group A-DS (2014) Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trial. Hepatol Res 44:73\u201382","journal-title":"Hepatol Res"},{"key":"1066_CR15","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","volume":"285","author":"PA McKee","year":"1971","unstructured":"McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441\u20131446","journal-title":"N Engl J Med"},{"key":"1066_CR16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02089953","volume":"14","author":"F Kruck","year":"1978","unstructured":"Kruck F, Bablok W, Besenfelder E, Betzien G, Kaufmann B (1978) Clinical and pharmacological investigations of the new saluretic azosemid. Eur J Clin Pharmacol 14:153\u2013156","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl","key":"1066_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00541464","volume":"31","author":"J Broekhuysen","year":"1986","unstructured":"Broekhuysen J, Deger F, Douchamps J, Ducarne H, Herchuelz A (1986) Torasemide, a new potent diuretic. Double-blind comparison with furosemide. Eur J Clin Pharmacol 31(Suppl):29\u201334","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl","key":"1066_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00541463","volume":"31","author":"L Dodion","year":"1986","unstructured":"Dodion L, Ambroes Y, Lameire N (1986) A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers. Eur J Clin Pharmacol 31(Suppl):21\u201327","journal-title":"Eur J Clin Pharmacol"},{"key":"1066_CR19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4240\/wjgs.v8.i5.353","volume":"8","author":"A Truong","year":"2016","unstructured":"Truong A, Hanna MH, Moghadamyeghaneh Z, Stamos MJ (2016) Implications of preoperative hypoalbuminemia in colorectal surgery. World J Gastrointest Surg 8:353\u2013362","journal-title":"World J Gastrointest Surg"},{"key":"1066_CR20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982\u2013992","journal-title":"Am J Kidney Dis"},{"key":"1066_CR21","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.09.011","volume":"119","author":"M Gheorghiade","year":"2006","unstructured":"Gheorghiade M, Filippatos G, De Luca L, Burnett J (2006) Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med 119:S3\u2013S10","journal-title":"Am J Med"},{"key":"1066_CR22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00392-015-0896-2","volume":"105","author":"JM Maaten ter","year":"2016","unstructured":"ter Maaten JM, Valente MA, Metra M, Bruno N, O\u2019Connor CM, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Dittrich HC, van Veldhuisen DJ, Hillege HL, Damman K, Voors AA (2016) A combined clinical and biomarker approach to predict diuretic response in acute heart failure. Clin Res Cardiol 105:145\u2013153","journal-title":"Clin Res Cardiol"},{"key":"1066_CR23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/cells4040622","volume":"4","author":"M Duffy","year":"2015","unstructured":"Duffy M, Jain S, Harrell N, Kothari N, Reddi AS (2015) Albumin and furosemide combination for management of edema in nephrotic syndrome: a review of clinical studies. Cells 4:622\u2013630","journal-title":"Cells"},{"key":"1066_CR24","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1681\/ASN.V1251010","volume":"12","author":"N Chalasani","year":"2001","unstructured":"Chalasani N, Gorski JC, Horlander JC Sr, Craven R, Hoen H, Maya J, Brater DC (2001) Effects of albumin\/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. J Am Soc Nephrol 12:1010\u20131016","journal-title":"J Am Soc Nephrol"},{"key":"1066_CR25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/1755-5922.12142","volume":"33","author":"T Okabe","year":"2015","unstructured":"Okabe T, Yakushiji T, Igawa W, Ono M, Kido T, Ebara S, Yamashita K, Yamamoto MH, Saito S, Hoshimoto K, Amemiya K, Isomura N, Araki H, Ochiai M (2015) The efficacy of tolvaptan in congestive heart failure patients with and without hypoalbuminemia: a pilot study. Cardiovasc Ther 33:275\u2013281","journal-title":"Cardiovasc Ther"},{"key":"1066_CR26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00535-015-1052-5","volume":"50","author":"I Sakaida","year":"2015","unstructured":"Sakaida I, Nakajima K, Okita K, Hori M, Izumi T, Sakurai M, Shibasaki Y, Tachikawa S, Tsubouchi H, Oka H, Kobayashi H (2015) Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan. J Gastroenterol 50:1047\u20131053","journal-title":"J Gastroenterol"},{"key":"1066_CR27","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10257","author":"Y Zhuang","year":"2016","unstructured":"Zhuang Y, Jia Z, Hu C, Ding G, Zhang X, Zhang Y, Yang G, Rohatgi R, Huang S, He JC, Zhang A (2016) Albuminuria confers renal resistance to loop diuretics via the stimulation of NLRP3 inflammasome\/prostaglandin signaling in thick ascending limb. Oncotarget. doi: 10.18632\/oncotarget.10257","journal-title":"Oncotarget"},{"issue":"Suppl 1","key":"1066_CR28","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1007\/s10557-011-6357-x","volume":"25","author":"M Furukawa","year":"2011","unstructured":"Furukawa M, Umehara K, Kashiyama E (2011) Nonclinical pharmacokinetics of a new nonpeptide V2 receptor antagonist, tolvaptan. Cardiovasc Drugs Ther 25(Suppl 1):S83\u2013S89","journal-title":"Cardiovasc Drugs Ther"},{"key":"1066_CR29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/nep.12348","volume":"20","author":"ES Park","year":"2015","unstructured":"Park ES, Huh YS, Kim GH (2015) Is tolvaptan indicated for refractory oedema in nephrotic syndrome? Nephrology (Carlton) 20:103\u2013106","journal-title":"Nephrology (Carlton)"},{"key":"1066_CR30","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00467-013-2687-1","volume":"29","author":"M Shimizu","year":"2014","unstructured":"Shimizu M, Ishikawa S, Yachi Y, Muraoka M, Tasaki Y, Iwasaki H, Kuroda M, Ohta K, Yachie A (2014) Tolvaptan therapy for massive edema in a patient with nephrotic syndrome. Pediatr Nephrol 29:915\u2013917","journal-title":"Pediatr Nephrol"},{"key":"1066_CR31","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS, TEMPO 3:4 Trial Investigators (2012) Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367:2407\u20132418","journal-title":"N Engl J Med"},{"key":"1066_CR32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1536\/ihj.13-221","volume":"55","author":"T Imamura","year":"2014","unstructured":"Imamura T, Kinugawa K, Minatsuki S, Muraoka H, Kato N, Inaba T, Maki H, Hatano M, Yao A, Komuro I (2014) Urine sodium excretion after tolvaptan administration is dependent upon baseline serum sodium levels: a possible explanation for the improvement of hyponatremia with scarce chance of hypernatremia by a vasopressin receptor antagonist. Int Heart J 55:131\u2013137","journal-title":"Int Heart J"},{"key":"1066_CR33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2215\/CJN.06540810","volume":"6","author":"A Blanchard","year":"2011","unstructured":"Blanchard A, Frank M, Wuerzner G, Peyrard S, Bankir L, Jeunemaitre X, Azizi M (2011) Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent. Clin J Am Soc Nephrol 6:753\u2013759","journal-title":"Clin J Am Soc Nephrol"},{"key":"1066_CR34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s10157-009-0196-0","volume":"13","author":"T Okada","year":"2009","unstructured":"Okada T, Sakaguchi T, Hatamura I, Saji F, Negi S, Otani H, Muragaki Y, Kawachi H, Shigematsu T (2009) Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats. Clin Exp Nephrol 13:438\u2013446","journal-title":"Clin Exp Nephrol"},{"key":"1066_CR35","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1038\/s41598-017-06579-0","volume":"7","author":"WH Lim","year":"2017","unstructured":"Lim WH, Choi EK, Han KD, Rhee TM, Lee HJ, Lee SR, Kang SH, Cha MJ, Oh S (2017) Proteinuria detected by urine dipstick test as a risk factor for atrial fibrillation: a nationwide population-based study. Sci Rep 7:6324","journal-title":"Sci Rep"},{"key":"1066_CR36","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4254\/wjh.v7.i12.1685","volume":"7","author":"T Ohki","year":"2015","unstructured":"Ohki T, Sato K, Yamada T, Yamagami M, Ito D, Kawanishi K, Kojima K, Seki M, Toda N, Tagawa K (2015) Efficacy of tolvaptan in patients with refractory ascites in a clinical setting. World J Hepatol 7:1685\u20131693","journal-title":"World J Hepatol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-017-1066-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-017-1066-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-017-1066-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T03:03:57Z","timestamp":1659668637000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-017-1066-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["1066"],"URL":"https:\/\/doi.org\/10.1007\/s00380-017-1066-4","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]}}}